Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 224-929-8 | CAS number: 4559-86-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- other: NMRI / Crl:NMRI
- Sex:
- female
- Details on test animals and environmental conditions:
- Species: Mice (non-pregnant, nulliparous, healthy)
Breeder: Charles River Laboratories, Germany
Number of animals: 30 (5 groups of 6 female animals each)
Body weight (on test day 1): 28 - 35 g
Age (on test day 1): 63 days
Adaptation period: At least 5 days
Diet: Commercial diet ssniff® R/M-H V1534. This food was offered ad libitum. Food residue was removed.
Housing: Before application the animals were housed in groups in MAKROLON cages (type III) with a basal surface of approx. 39 cm x 23 cm and a height of approx. 15 cm at a room temperature of 22 +/- 3°C (maximum range) and a relative humidity of 55 +/- 15% (maximum range). After application the animals were housed singly in order to prevent their licking off the test item from the ears of the other animals. The rooms were alternately lit (150 lux at approx. 1.50 m room height) and darkened for periods of 12 hours each.
Drinking water: Tap water was offered ad libitum - Vehicle:
- other: acetone/olive oil (3+1, v/v)
- Concentration:
- 0, 25, 50 or 100%
- No. of animals per dose:
- 5 groups of 6 female animals each were examined
- Details on study design:
- Preparation of the test item: The test item was diluted with acetone/olive oil (3+1, v/v), where appropriate.
Administration: The test item suspension was administered to the dorsum of both animal's ears at an application volume of 25 µL/ear.
Positive control
Route of administration: Open application to the dorsum of both ears
Administration volume: 25 µL/ear
Concentration 25% (v/v)
Positive controls were used to demonstrate appropriate performance of the assay and competence of the laboratory to successfully conduct the assay. An index for the lymph node cell count above 1.4 is considered positive.
Preliminary experiment
A preliminary experiment was carried out in 3 animals to examine the irritating potential and handling/application of the test item in order to select the appropriate concentrations. Three concentrations of 25 and 50% of Tetrabutylurea in acetone/olive oil (3+1, v/v) and the undiluted test item (100%) were examined. Doses were selected according to OECD guideline from the concentration series 100%, 50%, 25%, 10%, 5%, 2.5%, 1%, 0.5% etc. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- yes
- Positive control results:
- see below
- Parameter:
- SI
- Remarks on result:
- other: see table below
- Interpretation of results:
- ambiguous
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The test item showed strongly irritating properties in this test system as evident from the increased ear weight and ear thickness. Hence, no valid information on possible sensitising properties can be obtained for the test item in the local lymph node assay in mice as the increase in cell count might be caused by the irritating properties.
- Executive summary:
The purpose of this study was to determine the sensitising potential of Tetrabutylurea in the local lymph node assay in mice. The study was performed according to OECD 429, however not employing the use of radioactive labelling to measure cell proliferation, as the radioactive method proposed by the OECD guideline led to problems in various EU laboratories: such as (i) practical difficulties/complexity of the test, in particular the radiochemical steps, which sometimes resulted in loss of specimen/activity; this in turn led to variability in the results and to a poor reproducibility and (ii) radiation protection tssues. However, the OECD guideline allows other endpoints for assessment of proliferation in form of lymph node cell counts and lymph node weights if justification and appropriate scientific support exist showing the validity of this method. The alternative method used for the study employing the lymph node weight and lymph node cell count to assess proliferation has been established by a European interlaboratory validation exercise. This method has the advantage of (i) more simplistic experimental work, (ii) less variability, (iii) better reproducibility, (iv) faster results, (v) reduced costs. In addition, the acute inflammatory skin reaction is measured by ear weight determination of circular biopsies of the ears and ear thickness measurements on test day 1 and test day 4 to identify skin irritation properties of the test item. It is important to determine if a positive test result is due to the skin irritation potential of the test item or due to its sensitising properties. Stimulation indices were calculated for the lymph node cell count, lymph node weight, ear weight and ear thickness by dividing the average values per group of the test item treated animals by the vehicle treated ones. Values above 1.4 (lymph node cell count to identify sensitisation) or 1.1 (ear weight to identify irritation) are considered positive (these values were fixed empirically during the inter-laboratory validation of this method.
Three concentrations of Tetrabutylurea (25% and 50%, w/w) diluted with acetone/olive oil (3+1, v/v) and the undiluted test item were tested in six female NMRI mice per group and compared to a vehicle control group. In addition, a positive control group (25% solution (v/v) of alpha-hexyl cinnamic aldehyde in acetone/olive oil (3+1, v/v)) was employed.
Treatment with Tetrabutylurea at concentrations of 25% and 50 or the undiluted test item revealed statistically significant increased values for lymph node cell count and lymph node weights. However, ear weights and ear thickness were also increased at all 3 concentrations pointing to strongly irritating properties on the mouse ear. The stimulation indices of the lymph node cell count and ear weight exceeded the threshold levels of 1.4 or 1.1. The increase in lymph node weight was concentration-related and significant. The positive control group caused the expected increases in lymph node cell count and lymph node weight. Therefore, the study can be regarded as valid.
No signs of local or systemic intolerance were recorded. The animal body weight was not affected by the treatment. The test item showed strongly irritating properties in this test system as evident from the increased ear weight and ear thickness. Hence, no valid information on possible sensitising properties can be obtained for the test item in the local lymph node assay in mice as the increase in cell count might be caused by the irritating properties.
Reference
Main study results: stimulation indices (SI):
Parameter |
Group 1, negative control |
Group 2, 25% |
Group 3, 50% |
Group 4, 100% |
Group 5, positive control |
Lymph node cell count |
1.000 |
2.714 |
3.142 |
3.641 |
2.008 |
Lymph node weight |
1.000 |
2.486 |
3.286 |
3.371 |
2.657 |
Ear weight |
1.000 |
1.136 |
1.621 |
1.811 |
1.095 |
Difference of ear thickness |
1.000 |
1.102 |
1.322 |
1.593 |
1.157 |
____ significantly different from control at p ≤ 0.01
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
1,1,3,3-tetrabutylurea was tested in a Local Lymph Node Assay according to OECD Guideline 429 with GLP compliance. The test item showed strongly irritating properties in this test system as evident from the increased ear weight and ear thickness. Hence, no valid information on possible sensitising properties can be obtained for the test item in the local lymph node assay in mice as the increase in cell count might be caused by the irritating properties.
In an older GPMT, which cannot finally be evaluated (original reference not available), the application of the test substance to the shaved and intact skin caused moderate to no irritation, but no skin sensitisation.
Therefore it can be assumed, that 1,1,3,3-tetrabutylurea has no significant skin sensitisation properties.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
From the available studies it can be assumed, that 1,1,3,3-tetrabutylurea has no significant skin sensitisation properties. Therefore, there is no need for classification and labelling.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.